Clene Nanomedicine Announces Preclinical Results of A Novel Gold Nanocrystal Remyelinating Treatment for Multiple Sclerosis at ACTRIMS Forum Annual Meeting

February 2, 2018

Responsive image

SALT LAKE CITY, Feb. 2, 2018 /PRNewswire/ — Clene Nanomedicine, Inc., a clinical-stage biopharmaceutical company developing a new class of Clean Surface Nanotherapeutic (CSNTM) drugs using an electro-crystal-chemistry drug development platform, announced today results from multiple…

Category: Precious Metals